Collexis Announces SEC Filing

Focus on Science, Technical & Medical Markets to Fuel Future Growth

COLUMBIA, S.C., Nov. 2 /PRNewswire-FirstCall/ -- Collexis Holdings, Inc. (OTC
Bulletin Board: CLXS), a leading developer of semantic technology and
knowledge discovery software, announced today that it has voluntarily filed a
Form 15 with the United States Securities and Exchange Commission to terminate
the company's SEC reporting obligations. With the filing of the report, the
company's obligation to file periodic and current reports with the SEC,
including Forms 10-K, 10-Q and 8-K, is immediately suspended.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )

Collexis CEO Bill Kirkland explained, "We were pursuing a significant growth
strategy early in fiscal 2009 including acquisitions supported by large
fundraisings to achieve growth, with the ultimate goal of positioning the
Company for a NASDAQ listing. However, since the collapse of the global
markets, Collexis had to adapt and move our strategy towards organic growth in
our core markets. We divested our legal research business to focus and invest
in our growing Science, Technical, and Medical (STM) business. The STM
business, we believe, can grow substantially in fiscal 2010 and may allow us
to achieve positive operational cash flow by our fiscal year end. However,
the significant costs we incur on services and fees related to our public
filings and status do not contribute to our operational growth and are an
impediment to achieving our cash flow goals. With the approval of our Board,
management decided that our available resources are better focused on our
business growth rather than on remaining a public company."

Mr. Kirkland added, "There are a lot of other tangible advantages for us as
well. The work we put in to remain public is a significant drain on our
management's time and attention and does not contribute to our financial
success. I believe our current plans as a non-reporting entity will let us
maximize our company's potential for our shareholders over time."

About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic technology and
knowledge discovery software is headquartered in Columbia, South Carolina
(USA) with operations in Cologne, Germany and Valparaiso, Chile. Collexis now
offers the world's first pre-populated scientific social network for life
science researchers, www.biomedexperts.com. Collexis' proprietary technology
builds conceptual profiles of text, called Fingerprints, from documents,
Websites, emails and other digitized content and matches them with a
comprehensive list of pre-defined "fingerprinted" concepts to make research
results more relevant and efficient. This matching of concepts eliminates the
ambiguity and lack of priority associated with word searches. The results are
often described as "finding needles in many haystacks." Through this novel
approach, Collexis can build unique applications to search, index and
aggregate information as well as prioritize, trend and predict data based on
sources in multiple industries without the limitations of language or dialect.
Collexis' current clients in the public, private and academic sectors include
Johns Hopkins University; Dana-Farber Cancer Institute, the University of
California, San Francisco; the University of South Carolina; Erasmus
University Library; Lockheed Martin; the World Health Organization; Wellcome
Trust; the National Institutes of Health; and the U.S. Department of Defense.

Forward-Looking Statements
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties associated with our STM
business. These risks and uncertainties are in addition to other factors
detailed from time to time in the company's filings with the SEC, including
the section entitled "Risk Factors" in its transition report on Form 10-K for
the period ended June 30, 2008. The company cautions investors that any
forward-looking statements made by the company are not necessarily indicative
of future performance. The company is not responsible for updating the
information contained in this press release beyond the published date, or for
changes made to this document by wire services or Internet services.

SOURCE Collexis Holdings, Inc.

Darrell W. Gunter, EVP/CMO, Collexis Holdings, Inc., Mobile +1-973-454-3475,
Office +1-973-762-9715, gunter@collexis.com